Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer
Recruiting
N/A
Interventional Study
Endometrial Cancer
Hypofractionated Dose
Radiotherapy, Adjuvant
Side Effects
Survival , Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Xiaorong Hou · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
1. Study Type: Single-center, single-arm, prospective study.
2. Sample Size: 20 patients with high-risk endometrial cancer were enrolled.
3. Treatment Procedure:
The existing clinical oART (Online Adaptive Radiotherapy) workflow protocol for malignant tumors used in our department was applied.
Procedures included simulation, target volume delineation, radiotherapy planning, and treatment d…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age : 18-70 years old.
* Performance Status :
ECOG score 0-2.
* Expected to comply with oART (Online Adaptive Radiotherapy) workflow.
* Initial Surgical Treatment :
Total hysterectomy and bilateral salpingo-oophorectomy ± Pelvic and/or para-aortic lymph node dissection/samp…
Contacts